Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Cardiac Imaging|January 1, 1991
Localization of ectopic ventricular depolarization by ISPECT-radionuclide ventriculography and by magnetocardiography. ISPECT and MCG for ectopic mappingV Hombach, M Kochs, P Weismüller, et al.
European Journal of Nuclear Medicine|January 1, 1989
The contraction fraction (CF) in myocardial studies with technetium-99m-isonitrile (MIBI)--correlations with radionuclide ventriculography and infarct size measured by SPECTM Clausen, E Henze, A Schmidt, et al.
Zeitschrift Fur Kardiologie|August 1, 1990
[Localization of premature and ectopic ventricular depolarization using a new nuclear medicine tomographic technique]P Weismüller, M Clausen, E Henze, et al.
Oncology|June 3, 2008
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancerD Laessig, H J Stemmler, U Vehling-Kaiser, et al.
Oncology|April 6, 2005
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancerJ Stemmler, W Mair, M Stauch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancerS Boeck, T Hoehler, G Seipelt, et al.
Leukemia|June 5, 2012
The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cellsP Glorius, A Baerenwaldt, C Kellner, et al.
European Journal of Nuclear Medicine|January 1, 1993
Protocols for selection of cardiac radionuclide studies for use as a data base of normal studies and typical patterns of diseases. COST B2 Working Group II, in association with relevant working/task groups of the European Association of Nuclear Medicine and the European Society of CardiologyM H Bourguignon, E B Sokole, B Jones, et al.
International Journal of Cancer|August 19, 2015
Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial)A Stahler, V Heinemann, C Giessen-Jung, et al.
British Journal of Cancer|July 14, 2011
Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trialS Stintzing, L Fischer von Weikersthal, U Vehling-Kaiser, et al.
Pageof 14